OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions
Benjamin Ongnok, Nipon Chattipakorn, Siriporn C. Chattipakorn
Experimental Neurology (2019) Vol. 324, pp. 113118-113118
Closed Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 187

Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
Asal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 189-213
Closed Access | Times Cited: 148

Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 117

Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies
Pritee Chunarkar Patil, Mohammed Kaleem, Richa Mishra, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 201-201
Open Access | Times Cited: 79

The function of natural compounds in important anticancer mechanisms
Yang Nan, Hongchan Su, Bo Zhou, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 41

Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 101

Berberine ameliorates doxorubicin-induced cognitive impairment (chemobrain) in rats
Fatma H. Shaker, Marwa O. El-Derany, Sara A. Wahdan, et al.
Life Sciences (2021) Vol. 269, pp. 119078-119078
Closed Access | Times Cited: 71

Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways
Shaimaa S. Ibrahim, Omar G. Abo Elseoud, Mohamed H. Mohamedy, et al.
Neuropharmacology (2021) Vol. 197, pp. 108738-108738
Closed Access | Times Cited: 58

Donepezil Protects Against Doxorubicin-Induced Chemobrain in Rats via Attenuation of Inflammation and Oxidative Stress Without Interfering With Doxorubicin Efficacy
Benjamin Ongnok, Thawatchai Khuanjing, Titikorn Chunchai, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 3, pp. 2107-2125
Open Access | Times Cited: 56

Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions
Silvia Squillace, Daniela Salvemini
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 9, pp. 726-739
Open Access | Times Cited: 55

Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors
Lachlan McDowell, June Corry, Jolie Ringash, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 50

Neuroprotective Potential of Berberine Against Doxorubicin-Induced Toxicity in Rat’s Brain
Ghadha Ibrahim Fouad, Kawkab A. Ahmed
Neurochemical Research (2021) Vol. 46, Iss. 12, pp. 3247-3263
Closed Access | Times Cited: 42

Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30

Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment
Silvia Squillace, Michael L. Niehoff, Timothy M. Doyle, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 17
Open Access | Times Cited: 29

Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation
Marwa A. Ali, Esther T. Menze, Marianne Tadros, et al.
Neuropharmacology (2020) Vol. 181, pp. 108334-108334
Closed Access | Times Cited: 47

Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents
Run Yang, Changming Tan, Masoud Najafi
Inflammopharmacology (2021) Vol. 30, Iss. 1, pp. 73-89
Closed Access | Times Cited: 40

Bioinspired Andrias davidianus-Derived wound dressings for localized drug-elution
Xiang Liu, Xiang Mao, Ye Guo, et al.
Bioactive Materials (2022) Vol. 15, pp. 482-494
Open Access | Times Cited: 27

Galangin mitigates DOX-induced cognitive impairment in rats: Implication of NOX-1/Nrf-2/HMGB1/TLR4 and TNF-α/MAPKs/RIPK/MLKL/BDNF
Sarah A. Abd El‐Aal, Mohamed Abdelrahman, Ahmed Reda, et al.
NeuroToxicology (2022) Vol. 92, pp. 77-90
Closed Access | Times Cited: 25

Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23

Redox Interactions in Chemo/Radiation Therapy-induced Lung Toxicity; Mechanisms and Therapy Perspectives
Xixi Lai, Masoud Najafi
Current Drug Targets (2022) Vol. 23, Iss. 13, pp. 1261-1276
Closed Access | Times Cited: 22

Advances of metallodrug-amyloid β aggregation inhibitors for therapeutic intervention in neurodegenerative diseases: Evaluation of their mechanistic insights and neurotoxicity
Huzaifa Yasir Khan, Azeem Ahmad, Md Nadir Hassan, et al.
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215580-215580
Closed Access | Times Cited: 14

The Relationship between Cancer and Dementia: An Updated Review
Yung‐Shuo Kao, Cheng-Chang Yeh, Yifang Chen
Cancers (2023) Vol. 15, Iss. 3, pp. 640-640
Open Access | Times Cited: 13

Page 1 - Next Page

Scroll to top